Corona Virus Disease 2019 (COVID-19) Prevention and Control Measures in Community: A Literature Review

Bhagawaty Kalikotay
{"title":"Corona Virus Disease 2019 (COVID-19) Prevention and Control Measures in Community: A Literature Review","authors":"Bhagawaty Kalikotay","doi":"10.3126/RUPANTARAN.V4I1.34016","DOIUrl":null,"url":null,"abstract":"  \n There is a new public health crises threatening the world with the emergence and spread of 2019 novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There have been around 25,300,975 reported cases of coronavirus disease 2019 (COVID-2019) and 848,673 reported deaths to date (30/08/2020). Extensive literature review of publicly available information to summarize sign and symptoms as well as prevention of COVID-19 was carried out. The disease is transmitted by inhalation or contact with infected droplets and the incubation period ranges from 2 to 14 days. The symptoms are usually fever, cough, sore throat, breathlessness, fatigue, malaise among others. The disease is mild in most people; in some (usually the elderly and those with comorbidities), it may progress to pneumonia, acute respiratory distress syndrome (ARDS) and multi organ dysfunction. Many people are asymptomatic. The case fatality rate is estimated to range from 2 to 3%. Diagnosis is by demonstration of the virus in respiratory secretions by special molecular tests. Common laboratory findings include elevated C-reactive protein (CRP). Prevention entails home isolation of suspected cases and those with mild illnesses and strict infection control measures at hospitals that include contact and droplet precautions.","PeriodicalId":278254,"journal":{"name":"Rupantaran: A Multidisciplinary Journal","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rupantaran: A Multidisciplinary Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3126/RUPANTARAN.V4I1.34016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

   There is a new public health crises threatening the world with the emergence and spread of 2019 novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There have been around 25,300,975 reported cases of coronavirus disease 2019 (COVID-2019) and 848,673 reported deaths to date (30/08/2020). Extensive literature review of publicly available information to summarize sign and symptoms as well as prevention of COVID-19 was carried out. The disease is transmitted by inhalation or contact with infected droplets and the incubation period ranges from 2 to 14 days. The symptoms are usually fever, cough, sore throat, breathlessness, fatigue, malaise among others. The disease is mild in most people; in some (usually the elderly and those with comorbidities), it may progress to pneumonia, acute respiratory distress syndrome (ARDS) and multi organ dysfunction. Many people are asymptomatic. The case fatality rate is estimated to range from 2 to 3%. Diagnosis is by demonstration of the virus in respiratory secretions by special molecular tests. Common laboratory findings include elevated C-reactive protein (CRP). Prevention entails home isolation of suspected cases and those with mild illnesses and strict infection control measures at hospitals that include contact and droplet precautions.
2019冠状病毒病(COVID-19)社区防控措施综述
随着2019年新型冠状病毒(2019- ncov)或严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)的出现和传播,一场新的公共卫生危机威胁着世界。到目前为止(2020年8月30日),已经报告了大约25,300,975例冠状病毒病2019 (COVID-2019)和848,673例死亡。对公开信息进行了广泛的文献综述,总结了COVID-19的体征和症状以及预防措施。该病通过吸入或接触受感染的飞沫传播,潜伏期为2至14天。症状通常是发烧、咳嗽、喉咙痛、呼吸困难、疲劳、不适等。这种疾病对大多数人来说是轻微的;在某些情况下(通常是老年人和有合并症的人),它可能发展为肺炎、急性呼吸窘迫综合征(ARDS)和多器官功能障碍。许多人没有症状。病死率估计在2%至3%之间。诊断是通过特殊的分子试验在呼吸道分泌物中证实病毒。常见的实验室结果包括c反应蛋白(CRP)升高。预防需要在家中隔离疑似病例和轻症患者,并在医院采取严格的感染控制措施,包括接触和飞沫预防措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信